Press release
Leading Growth Driver in the Non-Steroidal Anti-inflammatory Drugs Market in 2025: Rising Prevalence Of Chronic Pain To Drive Market Growth Driver's Influence
Non-Steroidal Anti-inflammatory Drugs Market
The non-steroidal anti-inflammatory drugs market is projected to expand due to the rising instances of chronic pain. Chronic pain, defined as discomfort persisting longer than six months, frequently results from arthritis, as reported by the CDC (Centers for Disease Control and Prevention) in April 2022. Non-steroidal anti-inflammatory drugs serve to alleviate injuries and manage chronic pain. The CDC's report reveals arthritis as a common source of lingering pain, affecting millions in the United States, with roughly a quarter of 15 million adults bearing severe joint pain associated with the condition. Consequently, the escalating occurrences of chronic pain significantly contribute to the growth momentum of the non-steroidal anti-inflammatory drugs market.
Get Your Non-Steroidal Anti-inflammatory Drugs Market Report Here:
https://www.thebusinessresearchcompany.com/report/non-steroidal-anti-inflammatory-drugs-global-market-report
What growth opportunities are expected to drive the non-steroidal anti-inflammatory drugs market's CAGR through 2034?
The market size for non-steroidal anti-inflammatory drugs has seen significant growth recently. The forecast projects an increase from $20.68 billion in 2024 to $22.1 billion in 2025, manifesting a compound annual growth rate (CAGR) of 6.8%. Several factors have contributed to this growth throughout the historic period, including chronic inflammatory conditions, management of pain after surgery, sports-related injuries, over-the-counter accessibility, an aging demographic, and increased consumer awareness.
Rapid expansion is anticipated in the non-steroidal anti-inflammatory drugs market in the upcoming years. Its value is projected to reach $28.79 billion by 2029 with a compound annual growth rate (CAGR) of 6.8%. The projected growth during this period can be attributed to factors such as the emergence of new pain management therapies, changes in regulations, the application of telehealth, global wellness movements, competition from biosimilars, patient choices, and the application of precision medicine. The forecast period is expected to see more trends such as dominance of over-the-counter (OTC) market, increased inclination towards cox-2 inhibitors, generics and market competitors, and the adoption of digital health technologies.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8023&type=smp
What are the emerging trends shaping the future of the non-steroidal anti-inflammatory drugs market?
In the non-steroidal anti-inflammatory drugs market, the primary trend is the innovation of products. The leading entities in this market sphere are focusing on inventing new technological resolutions. Illustratively, Endo International plc, a pharmaceutical industry leader based in Ireland, introduced ibuprofen-famotidine 800 mg/26.6 mg tablets in March 2024. These tablets bind the pain-relieving and anti-inflammatory features of ibuprofen with famotidine's protective effects on the stomach. The purpose of this formulation is to soothe pain while simultaneously decreasing the likelihood of experiencing gastrointestinal side effects that can happen during the prolonged use of non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen.
Which growth-oriented segments of the non-steroidal anti-inflammatory drugs market are leading the industry's development?
The non-steroidal anti-inflammatory drugs market covered in this report is segmented -
1) By Route Of Administration: Oral, Topical, Other Route Of Administration
2) By Disease Indication: Arthritis, Migraine, Ophthalmic Diseases, Other Disease Indications
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
Subsegments:
1) By Oral: Tablets, Capsules, Liquids Or Solutions
2) By Topical: Gels, Creams, Patches
3) By Other Route Of Administration: Injectable (Intravenous And Intramuscular), Suppositories
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8023
What regions are leading the charge in the non-steroidal anti-inflammatory drugs market?
North America was the largest region in the non-steroidal anti-inflammatory drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the non-steroidal anti-inflammatory drugs market during the forecast period. The regions covered in the non-steroidal anti-inflammatory drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What companies are at the forefront of innovation in the non-steroidal anti-inflammatory drugs market?
Major companies operating in the non-steroidal anti-inflammatory drugs market are Pfizer Inc., Bayer AG, Johnson & Johnson, Sun Pharmaceutical Industries Ltd., Assertio Therapeutics Inc., Iroko Pharmaceuticals Inc., Reckitt Benckiser Group PLC, Perrigo Company PLC, Hikma Pharmaceuticals Public Limited Company, Glenmark Pharmaceuticals Limited, Septodont, Aspen Pharmacare Holdings Limited, Sagent Pharmaceuticals Inc., Advanced Pharma Inc., Akorn Operating Company LLC, Alembic Pharmaceuticals Limited, Torrent Pharmaceuticals Limited, Lupin Limited, Cipla Limited, Zydus Cadila Healthcare Limited, Aurobindo Pharma Limited, Sanofi S.A., GlaxoSmithKline PLC, Horizon Therapeutics PLC, Zyla Life sciences, Novartis AG, Roche Holding AG, AbbVie Inc., Bristol-Myers Squibb Company
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=8023&type=smp
What Is Covered In The Non-Steroidal Anti-inflammatory Drugs Global Market Report?
• Market Size Forecast: Examine the non-steroidal anti-inflammatory drugs market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the non-steroidal anti-inflammatory drugs market for a structured understanding.
• Key Players Overview: Analyze major players in the non-steroidal anti-inflammatory drugs market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the non-steroidal anti-inflammatory drugs market.
• Segment Contributions: Evaluate how different segments drive overall growth in the non-steroidal anti-inflammatory drugs market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the non-steroidal anti-inflammatory drugs market.
• Industry Challenges: Identify potential risks and obstacles affecting the non-steroidal anti-inflammatory drugs market.
• Competitive Landscape: Review strategic developments in the non-steroidal anti-inflammatory drugs market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Leading Growth Driver in the Non-Steroidal Anti-inflammatory Drugs Market in 2025: Rising Prevalence Of Chronic Pain To Drive Market Growth Driver's Influence here
News-ID: 3937484 • Views: …
More Releases from The Business Research Company
Leading Companies Reinforcing Their Presence in the Silica Mineral Supplements M …
The silica mineral supplements market is gaining notable traction as consumers increasingly prioritize health and wellness. With rising interest in preventive care and new technological advancements, this sector is set for significant expansion. Let's explore the market's size, key drivers, leading companies, emerging trends, and the main segments shaping its future.
Market Size and Growth Outlook for the Silica Mineral Supplements Market
The silica mineral supplements market is projected to experience robust…
Global Trends Overview: The Fast-Paced Evolution of the Seed Protein Supplements …
The seed protein supplements market is gaining significant traction as consumers increasingly seek plant-based nutrition options. With evolving dietary preferences and technological advancements, this sector is poised for remarkable growth through the end of the decade. Below, we explore the market's size, key players, driving factors, trends, and segmentation to understand its future potential.
Projected Expansion of the Seed Protein Supplements Market Size Through 2029
The seed protein supplements market is set…
Market Structure, Emerging Trends, and Key Player Analysis in the Robotic Weldin …
The robotic welding fume extraction system market is rapidly evolving as industries prioritize safer and cleaner working environments. With the increasing use of robotic welding technologies and a focus on sustainable manufacturing, this sector is poised for significant growth. The following overview highlights the market's value projections, key players, prevailing trends, and segmentation details shaping this dynamic industry.
Projected Market Value and Growth Trajectory of the Robotic Welding Fume Extraction System…
Major Industry Participants Reinforcing Their Presence in the Robotic Biobanking …
The robotic biobanking systems sector is experiencing swift advancements, driven by growing needs in precision medicine and large-scale research initiatives. As automation becomes increasingly integral to laboratory operations, this market is set to expand significantly, offering promising opportunities and innovations in the years ahead. Let's explore the market size projections, key players, emerging trends, and segmentation details shaping this dynamic industry.
Expected Growth in the Robotic Biobanking Systems Market by 2029
The…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
